Search
01/01/2022
Parkinson's Disease Motor Subtypes Change with the Progression of the Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up
Santos García D, Canfield H, de Deus Fonticoba T, Cores Bartolomé C, Naya Ríos L, García Roca L, Martínez Miró C, Jesús S, Aguilar M, Pastor P, Cosgaya M, García Caldentey J, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Ávila Rivera MA, Gómez Mayordomo V, Nogueira V, Puente V, Dotor J, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Carrillo Padilla F, Martínez Castrillo JC, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Kulisevsky J, Blázquez Estrada M, Seijo M, Rúiz Martínez J, Valero C, Kurtis M, de Fábregues O, González Ardura J, Alonso Redondo R, Ordás C, López Díaz LM, McAfee D, Martinez-Martin P, Mir P, COPPADIS Study Group. Parkinson's Disease Motor Subtypes Change with the Progression of the Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up. Journal of Parkinsons Disease. 2022; 12(3)DOI:10.3233/JPD-213004. PMID:34957949. IF:5.200(Q1/3D).
16/12/2021
Predictors of clinically significant quality of life impairment in Parkinson's disease
Garcia, DS, Fonticoba, TD, Cores, C, Munoz, G, Gonzalez, JMP, Miro, CM, Suarez, E, Jesus, S, Aguilar, M, Pastor, P, Planellas, L, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Catalan, MJ, Nogueira, V, Puente, V, de Arcos, MR, Borrue, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Padilla, FC, Castrillo, JCM, Alonso, PS, Losada, MGA, Ariztegui, NL, Gaston, I, Clavero, P, Kulisevsky, J, Estrada, MB, Seijo, M, Martinez, JR, Valero, C, Kurtis, M, de Fabregues, O, Ardura, JG, Ordas, C, Diaz, LML, McAfee, D, Martinez-Martin, P, Mir, P. Predictors of clinically significant quality of life impairment in Parkinson's disease. npj Parkinsons Disease. 2021; 7(1)DOI:10.1038/s41531-021-00256-w. PMID:34916528. IF:9.304(Q1/1D).
08/12/2021
Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson's disease
Martinez-Horta, S, Bejr-Kasem, H, Horta-Barba, A, Pascual-Sedano, B, Santos-Garcia, D, De Deus-Fonticoba, T, Jesus, S, Aguilar, M, Planellas, L, Garcia-Caldentey, J, Caballol, N, Vives-Pastor, B, Hernandez-Vara, J, Cabo-Lopez, I, Lopez-Manzanares, L, Gonzalez-Aramburu, I, Avila-Rivera, MA, Catalan, MJ, Lopez-Diaz, LM, Puente, V, Garcia-Moreno, JM, Borrue, C, Solano-Vila, B, Alvarez-Sauco, M, Vela, L, Escalante, S, Cubo, E, Carrillo-Padilla, F, Martinez-Castrillo, JC, Sanchez-Alonso, P, Alonso-Losada, MG, Lopez-Ariztegui, N, Gaston, I, Blazquez-Estrada, M, Seijo-Martinez, M, Ruiz-Martinez, J, Valero-Merino, C, Kurtis, M, De Fabregues-Boixar, O, Gonzalez-Ardura, J, Prieto-Jurczynska, C, Martinez-Martin, P, Mir, P, Kulisevsky, J. Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson's disease. BMC Neurology. 2021; 21(1)DOI:10.1186/s12883-021-02485-1. PMID:34879838. IF:2.903(Q3/7D).
01/12/2021
Diplopia Is Frequent and Associated with Motor and Non-Motor Severity in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up
Garcia, DS, Rios, LN, Fonticoba, TD, Bartolome, CC, Roca, LG, Painceiras, MF, Miro, CM, Canfield, H, Jesus, S, Aguilar, M, Pastor, P, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, Puente, V, Dotor, J, Borrue, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Padilla, FC, Castrillo, JMC, Alonso, PS, Losada, MAG, Ariztegui, NL, Gaston, I, Kulisevsky, J, Estrada, MB, Seijo, M, Martinez, JR, Valero, C, Kurtis, M, de Fabregues, O, Ardura, JG, Redondo, RA, Ordas, C, Diaz, LLM, McAfee, D, Martinez-Martin, P, Mir, P. Diplopia Is Frequent and Associated with Motor and Non-Motor Severity in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up. Diagnostics. 2021; 11(12)DOI:10.3390/diagnostics11122380. PMID:34943619. IF:3.992(Q2/4D).
05/10/2021
Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease
Gaig, C, Compta, Y, Heidbreder, A, Marti, MJ, Titulaer, MJ, Crijnen, Y, Hogl, B, Lewerenz, J, Erro, ME, Garcia-Monco, JC, Nigro, P, Tambasco, N, Patalong-Ogiewa, M, Erdler, M, Macher, S, Berger-Sieczkowski, E, Hoftberger, R, Geis, C, Hutterer, M, Milan-Tomas, A, Martin-Bastida, A, Manzanares, LL, Quintas, S, Hoglinger, GU, Mohn, N, Schoberl, F, Thaler, FS, Asioli, GM, Provini, F, Plazzi, G, Berganzo, K, Blaabjerg, M, Bruggemann, N, Farias, T, Ng, CF, Giordana, C, Herrero-San Martin, A, Huebra, L, Kotschet, K, Liendl, H, Montojo, T, Morata, C, Perez, JP, Puertas, I, Seifert-Held, T, Seitz, C, Simabukuro, MM, Tellez, N, Villacieros-Alvarez, J, Willekens, B, Sabater, L, Iranzo, A, Cano, JS, Dalmau, J, Graus, F. Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease. NEUROLOGY. 2021; 97(14)DOI:10.1212/WNL.0000000000012639. PMID:34380749. IF:12.258(Q1/1D).
01/10/2021
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data
Pagano, G, Boess, FG, Taylor, KI, Ricci, B, Mollenhauer, B, Poewe, W, Boulay, A, Anzures-Cabrera, J, Vogt, A, Marchesi, M, Post, A, Nikolcheva, T, Kinney, GG, Zago, WM, Ness, DK, Svoboda, H, Britschgi, M, Ostrowitzki, S, Simuni, T, Marek, K, Koller, M, Sevigny, J, Doody, R, Fontoura, P, Umbricht, D, Bonni, A, PASADENA Investigators, Bejr-Kasem, H, Bojarsky J.K., Prasinezumab Study Grp. A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data. Frontiers in Neurology. 2021; 12DOI:10.3389/fneur.2021.705407. PMID:34659081. IF:4.086(Q2/5D).
01/09/2021
Gray Matter Vulnerabilities Predict Longitudinal Development of Apathy in Huntington's Disease
De Paepe, AE, Ara, A, Garcia-Gorro, C, Martinez-Horta, S, Perez-Perez, J, Kulisevsky, J, Rodriguez-Dechicha, N, Vaquer, I, Subira, S, Calopa, M, Munoz, E, Santacruz, P, Ruiz-Idiago, J, Mareca, C, de Diego-Balaguer, R, Camara, E. Gray Matter Vulnerabilities Predict Longitudinal Development of Apathy in Huntington's Disease. MOVEMENT DISORDERS. 2021; 36(9)DOI:10.1002/mds.28638. PMID:33998063. IF:9.698(Q1/1D).
01/08/2021
The role of glutamatergic neurotransmission in the motor and non-motor symptoms in Parkinson's disease: Clinical cases and a review of the literature
Pagonabarraga, J, Tinazzi, M, Caccia, C, Jost, WH. The role of glutamatergic neurotransmission in the motor and non-motor symptoms in Parkinson's disease: Clinical cases and a review of the literature. JOURNAL OF CLINICAL NEUROSCIENCE. 2021; 90DOI:10.1016/j.jocn.2021.05.056. PMID:34275546. IF:2.116(Q4/9D).
01/07/2021
Predictors of Global Non-Motor Symptoms Burden Progression in Parkinson's Disease. Results from the COPPADIS Cohort at 2-Year Follow-Up
Diego, SG, Teresa, DD, Cores, C, Canfield, H, Paz Gonzalez, JM, Miro, CM, Aymerich, LV, Suarez, E, Jesus, S, Aguilar, M, Pastor, P, Planellas, L, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Hernandez-Vara, J, Cabo, I, Manzanares, LL, Aramburu, IG, Avila Rivera, MA, Catalan, MJ, Nogueira, V, Puente, V, Dotor, J, Borrue, C, Solano, B, Alvarez Sauco, M, Vela, L, Escalante, S, Cubo, E, Carrillo, F, Martinez Castrillo, JC, Alonso, PS, Alonso, G, Ariztegui, NL, Gaston, I, Kulisevsky, J, Blazquez, M, Seijo, M, Ruiz Martinez, J, Valero, C, Kurtis, M, de Fabregues, O, Ardura, J, Alonso, R, Ordas, C, Diaz, LML, McAfee, D, Martinez-Martin, P, Mir, P, COPPADIS Study Group. Predictors of Global Non-Motor Symptoms Burden Progression in Parkinson's Disease. Results from the COPPADIS Cohort at 2-Year Follow-Up. Journal of Personalized Medicine. 2021; 11(7)DOI:10.3390/jpm11070626. PMID:34209166. IF:3.508(Q2/4D).
01/11/2023
Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial (August, 10.1038/s41591-021-01455-x, 2021)
Dam, T, Golbe, LI, Hoglinger, GU, Grundman, M, Yang, LL, Tidemann-Miller, B, Kupferman, J, Harper, K, Kamisoglu, K, Wald, MJ, Graham, DL, Gedney, L, O'Gorman, J, Haeberlein, SB, Aiba, I, Antonini, A, Apetauerova, D, Azulay, JP, Martinez, EB, Bang, J, Barone, P, Barrett, M, Bega, D, Berg, D, Corrales, KB, Bordelon, Y, Boxer, AL, Brandt, M, Brueggemann, N, Castelnovo, G, Ceravolo, R, Chuang, RD, Chung, SJ, Church, A, Corvol, JC, Cudia, P, Dale, M, Defebvre, L, Drapier, S, Driver-Dunckley, ED, Ebersbach, G, Eggert, KM, Ellenbogen, A, Eusebio, A, Evans, AH, Fedorova, N, Finger, E, Foubert-Samier, A, Ghosh, B, Golbe, L, Perez, FG, Grossman, M, Hall, D, Hamada, K, Hasegawa, K, Hoeglinger, G, Honig, L, Houghton, D, Huang, XM, Isaacson, S, Koh, S, Bojarski, JK, Lang, ANE, Leigh, PN, Litvan, I, Lozano, JJL, Moreno, JLLS, Ludolph, AC, Piudo, MRL, Torres, IM, McFarland, N, Meissner, W, Mestre, T, Rivera, PM, Molho, E, Mollenhauer, B, Morris, HR, Murata, M, Obi, T, Magne, FO, O'Suilleabhain, P, Pahwa, R, Pantelyat, A, Pavese, N, Pokhabov, D, Prudlo, J, Rodriguez-Porcel, F, Rowe, J, Savitt, J, Schnitzler, A, Schulz, JB, Seppi, K, Shah, BI, Shill, H, Shprecher, D, Stamelou, M, Steiger, M, Takahashi, Y, Takigawa, H, Tartaglia, C, Toenges, L, Truong, D, Tse, W, Tuite, P, Volc, D, Wills, AMA, Woitalla, D, Xie, T, Yuasa, T, Zauber, SE, Zesiewicz, T. Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial (August, 10.1038/s41591-021-01455-x, 2021). NATURE MEDICINE. 2023; 29(11)DOI:10.1038/s41591-022-02076-8. PMID:36253611. IF:58.700(Q1/1D).
05/07/2023
Reduplicative paramnesia as an atypical form of presentation of a Heidenhain variant of Creutzfeldt-Jakob disease: A case report
Martinez-Horta, S, Marzal-Espi, CN, Cuso-Garcia, S, Aracil-Bolanos, I, Kulisevsky, J. Reduplicative paramnesia as an atypical form of presentation of a Heidenhain variant of Creutzfeldt-Jakob disease: A case report. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY. 2023; 29(6)DOI:10.1017/S1355617722000583. PMID:36062534. IF:2.600(Q2/4D).
01/03/2023
Genotype-Phenotype Correlations for ATX-TBP (SCA17): MDSGene Systematic Review
Rossi M., Hamed M., Rodríguez-Antigüedad J., Cornejo-Olivas M., Breza M., Lohmann K., Klein C., Rajalingam R., Marras C., van de Warrenburg B.P.. Genotype-Phenotype Correlations for ATX-TBP (SCA17): MDSGene Systematic Review. MOVEMENT DISORDERS. 2023; 38(3)DOI:10.1002/mds.29278. PMID:36374860. IF:7.400(Q1/1D).
01/01/2023
Non-Persistence of Tremorolytic Effect of Perampanel in Essential Tremor: Real-World Experience with 50 Patients
Gironell A., Pascual-Sedano B., Marín-Lahoz J., Pérez J., Pagonabarraga J.. Non-Persistence of Tremorolytic Effect of Perampanel in Essential Tremor: Real-World Experience with 50 Patients. Movement Disorders Clinical Practice. 2023; 10(1)DOI:10.1002/mdc3.13576. PMID:36704076. IF:2.600(Q2/5D).
01/01/2023
Autism Spectrum Disorder May Be Highly Prevalent in People with Functional Neurological Disorders
Gonzalez-Herrero, B, Morgante, F, Pagonabarraga, J, Stanton, B, Edwards, MJ. Autism Spectrum Disorder May Be Highly Prevalent in People with Functional Neurological Disorders. Journal of Clinical Medicine. 2023; 12(1)DOI:10.3390/jcm12010299. PMID:36615098. IF:3.000(Q1/2D).
01/12/2022
Clinical and structural brain correlates of hypomimia in early-stage Parkinson's disease
Sampedro, F, Martinez-Horta, S, Horta-Barba, A, Grothe, MJ, Labrador-Espinosa, MA, Jesus, S, Adarmes-Gomez, A, Carrillo, F, Puig-Davi, A, Roldan-Lora, F, Aguilar-Barbera, M, Pastor, P, Arroyo, SE, Vila, BS, Cots-Foraster, A, Ruiz-Martinez, J, Carrillo-Padilla, F, Pueyo-Morlans, M, Gonzalez-Aramburu, I, Infante-Ceberio, J, Hernandez-Vara, J, de Fabregues-Boixar, O, Fonticoba, TD, Avila, A, Martinez-Castrillo, JC, Bejr-Kasem, H, Campolongo, A, Pascual-Sedano, B, Martinez-Martin, P, Santos-Garcia, D, Mir, P, Garcia-Ruiz, PJ, Kulisevsky, J. Clinical and structural brain correlates of hypomimia in early-stage Parkinson's disease. EUROPEAN JOURNAL OF NEUROLOGY. 2022; 29(12)DOI:10.1111/ene.15513. PMID:35852918. IF:5.100(Q1/3D).
01/12/2022
Predicting Impulse Control Disorders in Parkinson Disease through Incentive Biomarkers
Marin-Lahoz, J, Martinez-Horta, S, Pagonabarraga, J, Horta-Barba, A, Aracil-Bolanos, I, Bejr-kasem, H, Sampedro, F, Campolongo, A, Kulisevsky, J. Predicting Impulse Control Disorders in Parkinson Disease through Incentive Biomarkers. ANNALS OF NEUROLOGY. 2022; 92(6)DOI:10.1002/ana.26486. PMID:36054656. IF:11.200(Q1/1D).
01/12/2022
Endothelial NO synthase 786T/T polymorphism increases hemorrhagic transformation after endovascular thrombectomy
De la Riva, P, Rodriguez-Antiguedad, J, Gomez, V, Arenaza, G, Gorostidi, A, Diez, N, De Arce, A, Martinez-Zabaleta, M, Gonzalez, F, Luttich, A, Garmendia, E, Sola, A, Larrea, JA, Bergareche, A, Sobrino, T. Endothelial NO synthase 786T/T polymorphism increases hemorrhagic transformation after endovascular thrombectomy. NITRIC OXIDE-BIOLOGY AND CHEMISTRY. 2022; 129DOI:10.1016/j.niox.2022.08.006. PMID:36067953. IF:3.900(Q2/5D).
01/11/2022
Isolation of mitochondria-derived mitovesicles and subpopulations of microvesicles and exosomes from brain tissues
D'Acunzo, P, Kim, Y, Ungania, JM, Perez-Gonzalez, R, Goulbourne, CN, Levy, E. Isolation of mitochondria-derived mitovesicles and subpopulations of microvesicles and exosomes from brain tissues. Nature Protocols. 2022; 17(11)DOI:10.1038/s41596-022-00719-1. PMID:35962195. IF:14.800(Q1/1D).
01/11/2022
Risk of Parkinson's disease in a gout Mediterranean population: A case-control study
Pou, MA, Orfila, F, Pagonabarraga, J, Ferrer-Moret, S, Corominas, H, Diaz-Torne, C. Risk of Parkinson's disease in a gout Mediterranean population: A case-control study. JOINT BONE SPINE. 2022; 89(6)DOI:10.1016/j.jbspin.2022.105402. PMID:35504516. IF:4.200(Q2/5D).
01/10/2022
Polymorphisms in the oxytocin receptor and their association with apathy and impaired social cognition in Huntington's disease
Saiz-Rodriguez, M, Gil-Polo, C, Diez-Fairen, M, Martinez-Horta, SI, Santalo, FS, Calvo, S, Alonso-Garcia, E, Rinones-Mena, E, Aguado, L, Mariscal, N, Munoz-Siscart, I, Pineiro, D, Rivadeneyra, J, Cubo, E. Polymorphisms in the oxytocin receptor and their association with apathy and impaired social cognition in Huntington's disease. NEUROLOGICAL SCIENCES. 2022; 43(10)DOI:10.1007/s10072-022-06226-1. PMID:35725858. IF:3.300(Q2/5D).